Grants totaling $305,000 have been awarded for 2023. For more information on this year’s grantees, please visit the Washington Global Health Alliance website.

$808,000 Has been awarded in funding, creating jobs across the state and benefiting individuals throughout the world.

Our 2023 Grantees Include

Improving the Quality of Drug Testing MethodsThe Washington Global Health Fund (WGHF) was established to improve the quality of drug testing and promote job creation in the global health sector in Washington State.

Read More

Developing Microfluidic Devices for Drug TestingDeveloping Microfluidic devices for drug testing holds great promise for improving the accuracy and precision of drug testing. As the CEO of the Washington Global Health Fund, I am committed to advancing this technology and bringing it to market.

Read More

Aseptica, Inc.A novel agent used to disinfect catheters and other medical devices in the developing world.

Read More

Mirador BiomedicalPressure sensing device for diagnosing compartment syndrome

Read More

Cascade Designs, Inc.Chlorine-solution producing device for water treatment and sanitation.

Read More

BURN Design LabClean-burning, charcoal cook stoves to improve indoor air quality in East Africa.

Read More

PRONTO InternationalPRONTOPack: curriculum and supplies to aid birth simulations in low-resource settings.

Read More

SIGN Fracture Care InternationalWorking to obtain FDA approval and ISO certification on a pediatric nail and a hip plate.

Read More

See where we’ve received applications from around the state

WGHF facilitates grants to support commercialization.

Our research

What grantees are saying

In addition to monetary support, WGHF introduced us to members of Washington State’s global health community, including SIGN, a company who develops and distributes an innovative internal fixation device to treat severe bone fractures in the developing world. This is a great example of how you brought together two companies working in the global health space and made a real impact.Justin Hulvershorn, MD, PhD. Chief Science Officer, Mirador Biomedical

Doing The Right Things

73

Devices Produced

435.000

People benefited

12.000

Jobs Created